Designing peptide inhibitors for possible COVID-19
treatments

Scientists across the globe are rushing to find
inhibitors of SARS-CoV-2, the new coronavirus behind the COVID-19
pandemic. Some are using computer simulations to identify promising
compounds before conducting actual experiments in the lab. Now,
researchers reporting in ACS Nano have used computer modeling to
assess four peptides that mimic the virus-binding domain of the
human protein that allows SARS-CoV-2 to enter cells.